Speaker illustration

Ms Juliane Wagner

University of Pecs, Pecs (Hungary)

Spironolactone treatment does not cause significant hyperkalemia at patients hospitalized because of chronic or acute heart failure - a meta-analysis

Event: Heart Failure 2018

Topic: Pharmacotherapy

Session: Acute Heart Failure– Treatment

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb